Literature DB >> 7251095

The antihypertensive mechanism of clonidine in man. Evidence against a generalized reduction of sympathetic activity.

B G Wallin, M Frisk-Holmberg.   

Abstract

Recording of multi-unit sympathetic activity were made from muscle branches of the peroneal nerve during i.v. bolus injection of 100 to 275 micrograms clonidine in seven hypertensive patients. Blood pressure was reduced in all patients, but sympathetic activity and heart rate could either increase or decrease. When plasma levels of clonidine were low, sympathetic activity tended to increase, and when plasma levels were high, activity tended to decrease. Irrespective of whether mean level of sympathetic activity increased or decreased with the fall in blood pressure level, transient fluctuations of blood pressure continued to cause dynamic baroreflex modulation of the sympathetic outflow. It is suggested that the drug influences sympathetic outflow by a combination of central and peripheral effects.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7251095     DOI: 10.1161/01.hyp.3.3.340

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  3 in total

Review 1.  Central sympatholytic drugs.

Authors:  Wanpen Vongpatanasin; Kazuomi Kario; Steven A Atlas; Ronald G Victor
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-07-18       Impact factor: 3.738

2.  Relationship between the cardiovascular effects and steady-state kinetics of clonidine in hypertension. Demonstration of a therapeutic window in man.

Authors:  M Frisk-Holmberg; L Paalzow; L Wibell
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

3.  Effect of catecholamine depletion on increased blood pressure lability upon emergence from halothane anesthesia in rats: the role of sympathetic nervous activity in postanesthetic circulatory instability.

Authors:  Andrei Cividjian; Nicolas Rentero; Jean Marc Pequignot; Luc Quintin
Journal:  J Anesth       Date:  2008-05-25       Impact factor: 2.078

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.